FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jun Luo

Research Profile

Disorders

Physiology

Anatomy

Devices

Oligonucleotide Array Sequence Analysis

Chemicals & Drugs

Procedures

Living Beings

Mouse

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
John T Isaacs; Sushant Kachhap; Lizamma Antony; Anders Björk; Per Björk; W Nathaniel Brennen; Susan L Dalrymple; Stephanie Gerber; Hans-Joerg Hammers; Jun Luo; Anders Olsson; Michel Wissing; Li Xing; Tomas Leanderson
Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment.
Martin Aryee; G Steven Bova; Julia C Engelmann; David Esopi; Robert H Getzenberg; Meltem Gurel; Michael C Haffner; Rafael A Irizarry; William B Isaacs; Wennuan Liu; Jun Luo; William G Nelson; Philipp Nuhn; Jianfeng Xu; Srinivasan Yegnasubramanian
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
Jun Luo
Editorial comment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jun Luo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: John T Isaacs; Sushant Kachhap; Lizamma Antony; Anders Björk; Per Björk; W Nathaniel Brennen; Susan L Dalrymple; Stephanie Gerber; Hans-Joerg Hammers; Jun Luo; Anders Olsson; Michel Wissing; Li Xing; Tomas Leanderson
Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment.
Cancer research 2013;73(4):1386-99.
2013: Martin Aryee; G Steven Bova; Julia C Engelmann; David Esopi; Robert H Getzenberg; Meltem Gurel; Michael C Haffner; Rafael A Irizarry; William B Isaacs; Wennuan Liu; Jun Luo; William G Nelson; Philipp Nuhn; Jianfeng Xu; Srinivasan Yegnasubramanian
DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
Science translational medicine 2013;5(169):169ra10.
2012: Jun Luo
Editorial comment.
The Journal of urology 2012;188(6):2164; discussion 2164.
2012: John T Isaacs; Jun Luo; Georges H Ndikuyeze; Lizamma Antony; Shuangling Chen; Susan P Dalrymple; Jason M D'Antonio; Samuel R Denmeade
Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer.
The Prostate 2012;72(14):1491-505.
2012: Jie Li; Jun Luo; Christian P Pavlovich; Chang-Jun Yin; Robert H Getzenberg; Zhi-Hong Zhang; Wei Zhang
Effect of surgical procedures on prostate tumor gene expression profiles.
Asian journal of andrology 2012;14(5):708-14.
2012: Rong Hu; William B Isaacs; Changxue Lu; Elahe A Mostaghel; Peter S Nelson; Stephen R Plymate; Clare Tannahill; Srinivasan Yegnasubramanian; Eric Bluemn; Joanne Edwards; Meltem Gurel; Jun Luo
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
Cancer research 2012;72(14):3457-62.
2012: Thomas A Dunn; Helen L Fedor; Angelo M DeMarzo; Jun Luo
Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.
Asian journal of andrology 2012;14(3):385-92.
2011: Rong Hu; William B Isaacs; Jun Luo
A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities.
The Prostate 2011;71(15):1656-67.
2011: Takumi Shiraishi; Takahito Suyama; Naoki Terada; Bruce J Trock; Yu Zeng; PRAKASH KULKARNI; Jun Luo; Robert H Getzenberg
Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy.
Journal of translational medicine 2011;9():153.
2010: Takahito Suyama; Takumi Shiraishi; Yu Zeng; Wayne Yu; Nehal Parekh; Robert L Vessella; Jun Luo; Robert H Getzenberg; PRAKASH KULKARNI
Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
The Prostate 2010;70(16):1778-87.
2009: Judit Ribas; Xiaohua Ni; Michael Haffner; Erik A Wentzel; Amirali Hassanzadeh Salmasi; Wasim H Chowdhury; Tarana A Kudrolli; Srinivasan Yegnasubramanian; Jun Luo; Ronald Rodriguez; Joshua T Mendell; Shawn E Lupold
miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.
Cancer research 2009;69(18):7165-9.
2009: Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
Nature medicine 2009;15(5):559-65.
2009: Donna E Hansel; Masashi Nakayama; Jun Luo; Abde M Abukhdeir; Ben Ho Park; Charles J Bieberich; Jessica L Hicks; Mario A Eisenberger; William G Nelson; Jacek L Mostwin; Angelo M DeMarzo
Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
The Prostate 2009;69(6):603-9.
2009: Yu Cheng; Jin Woo Kim; Wennuan Liu; Thomas A Dunn; Jun Luo; Matthew J Loza; Seong-Tae Kim; S Lilly Zheng; Jianfeng Xu; William B Isaacs; Bao-Li Chang
Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.
The Prostate 2009;69(3):327-35.
2009: Thomas A Dunn; Helen Fedor; William B Isaacs; Angelo M DeMarzo; Jun Luo
Genome-wide expression analysis of recently processed formalin-fixed paraffin embedded human prostate tissues.
The Prostate 2009;69(2):214-8.
2009: Rong Hu; Thomas A Dunn; Shuanzeng Wei; Sumit Isharwal; Robert W Veltri; Elizabeth Humphreys; Misop Han; Alan W Partin; Robert L Vessella; William B Isaacs; G Steven Bova; Jun Luo
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.
Cancer research 2009;69(1):16-22.
2008: Shuanzeng Wei; Thomas A Dunn; William B Isaacs; Angelo M DeMarzo; Jun Luo
GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.
The Prostate 2008;68(13):1387-95.
2008: Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; William B Isaacs; Jun Luo; Angelo M DeMarzo
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1156-67.
2006: Thomas A Dunn; Shenglin Chen; Dennis A Faith; Jessica L Hicks; Elizabeth A Platz; Yidong Chen; Charles M Ewing; Jurga Sauvageot; William B Isaacs; Angelo M DeMarzo; Jun Luo
A novel role of myosin VI in human prostate cancer.
The American journal of pathology 2006;169(5):1843-54.
2006: Florian R Fritzsche; Edgar Dahl; Stefan Pahl; Mick Burkhardt; Jun Luo; Empar Mayordomo; Tserenchunt Gansukh; Anja Dankof; Ruth Knuechel; Carsten Denkert; Klaus-Jürgen Winzer; Manfred Dietel; Glen Kristiansen
Prognostic relevance of AGR2 expression in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1728-34.
2005: Steven R Schwarze; Jun Luo; William B Isaacs; David F Jarrard
Modulation of CXCL14 (BRAK) expression in prostate cancer.
The Prostate 2005;64(1):67-74.
2005: Shan Zha; Sacha Ferdinandusse; Jessica L Hicks; Simone Denis; Thomas A Dunn; Ronald J Wanders; Jun Luo; Angelo M DeMarzo; William B Isaacs
Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
The Prostate 2005;63(4):316-23.
2004: Dennis A Faith; William B Isaacs; James D Morgan; Helen Fedor; Jessica L Hicks; Leslie A Mangold; Patrick C Walsh; Alan W Partin; Elizabeth A Platz; Jun Luo; Angelo M DeMarzo
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
The Prostate 2004;61(3):215-27.
2004: Craig G Rogers; Gai Yan; Shan Zha; Mark L Gonzalgo; William B Isaacs; Jun Luo; Angelo M DeMarzo; William G Nelson; Christian P Pavlovich
Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.
The Journal of urology 2004;172(4 Pt 1):1501-3.
2004: Dennis R Chesire; Thomas A Dunn; Charles M Ewing; Jun Luo; William B Isaacs
Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells.
Cancer research 2004;64(7):2523-33.
2003: Shan Zha; Sacha Ferdinandusse; Simone Denis; Ronald J Wanders; Charles M Ewing; Jun Luo; Angelo M DeMarzo; William B Isaacs
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
Cancer research 2003;63(21):7365-76.
2003: Angelo M DeMarzo; Alan K Meeker; Shan Zha; Jun Luo; Masashi Nakayama; Elizabeth A Platz; William B Isaacs; William G Nelson
Human prostate cancer precursors and pathobiology.
Urology 2003;62(5 Suppl 1):55-62.
2003: Jun Luo; Thomas A Dunn; Charles M Ewing; Patrick C Walsh; William B Isaacs
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
The Prostate 2003;57(2):134-9.
2003: Cristina Magi-Galluzzi; Jun Luo; William B Isaacs; Jessica L Hicks; Angelo M DeMarzo; Jonathan I Epstein
Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
The American journal of surgical pathology 2003;27(8):1128-33.
2003: Jun Luo; William B Isaacs; Jeffrey M. Trent; David Duggan
Looking beyond morphology: cancer gene expression profiling using DNA microarrays.
Cancer investigation 2003;21(6):937-49.
2002: Jun Luo; Thomas Dunn; Charles M Ewing; Jurga Sauvageot; Yidong Chen; Jeffrey M. Trent; William B Isaacs
Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.
The Prostate 2002;51(3):189-200.
2002: Jun Luo; Shan Zha; Wesley R Gage; Thomas A Dunn; Jessica L Hicks; Christina J Bennett; Charles M Ewing; Elizabeth A Platz; Sacha Ferdinandusse; Ronald J Wanders; Jeffrey M. Trent; William B Isaacs; Angelo M DeMarzo
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Cancer research 2002;62(8):2220-6.
2001: Jun Luo; David Duggan; Yidong Chen; Jurga Sauvageot; Charles M Ewing; Michael Bittner; Jeffrey M. Trent; William B Isaacs
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
Cancer research 2001;61(12):4683-8.
1999: Jun Luo; David M Lubaroff; Mary J C Hendrix
Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection.
Cancer research 1999;59(15):3552-6.
1999: Navesh Sharma; Jun Luo; Dawn A Kirschmann; Yunxia Q O'Malley; Mike E Robbins; E T Akporiaye; David M Lubaroff; Paul M Heidger; Mary J C Hendrix
A novel immunological model for the study of prostate cancer.
Cancer research 1999;59(10):2271-6.